DDM-032 - Evaluating the biological activities of novel nanoformulation for colorectal cancer treatment using optimised IncuCyte-based methodologies

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: DDM-032
• By: SUR, Srija (Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Australia)
• Co-author(s): Ms Srija Sur (Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia)
  Ms Ghada Aboueid (Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia)
  Mr. Moien Sadeghi (Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia)
  Dr. Pegah Varamini (Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia / Sydney Nano Institute, The University of Sydney , Sydney, Australia)
  
• Abstract:

  Introduction: Colorectal cancer (CRC) is the third most prevalent cancer globally, accounting for 10% of all cases and the second leading cause of cancer-related mortality, as reported by World Health Organisation. Conventional treatments such as chemotherapy, radiotherapy, and immunotherapy lack specificity, leading to toxicity in normal cells...

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login